ClinicalTrials.Veeva

Menu

Duration of Exercise Program in Interstitial Lung Diseases.

I

Izmir Katip Celebi University

Status

Completed

Conditions

Interstitial Lung Disease

Treatments

Other: Exercise program

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

We aimed to compare the functional results of the 8th week with the results of the 12th week of the exercise programs applied to the patients with ILD.

Full description

Exercise programs (EP) have been shown to be the effective approach for functional outcomes in interstitial lung diseases (ILD). In many studies, the duration of exercise programs varies between 8-12 weeks. However, the optimal duration of exercise program is still unknown.

We aimed to compare the results of the 8th week with the results of the 12th week of the PR programs applied to the patients with ILD.

A total of 14 patients with ILD referred to our PR unit [11 idiopathic pulmonary fibrosis, 2 sarcoidosis (stage 3 and 4) and 1 nonspecific interstitial pneumonia] were included in the study. Pulmonary function test, arterial blood gas analysis, 6- minute walk test, mMRC dyspnea scale, quality of life questionnaires and hospital anxiety depression scale were performed before, at the 8th and 12th weeks after the exercise program applied to the patients twice a week.

Enrollment

14 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Completed the 12 week exercise program
  • Diagnosed with ILD

Exclusion criteria

  • Not completed 12 week exercise program

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

14 participants in 1 patient group

Exercise program
Other group
Description:
Treatment group
Treatment:
Other: Exercise program

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems